Backed by $3 million in inception funding from Sierra Ventures and other investors, Thrixel introduces part-based 3D ...

Sukkot at Westchester Day School had the whole campus buzzing last week with creative art projects, exciting field trips, ...

Argenx said it would discontinue its Phase 3 Unity study of Efgartigimod SC in adults with moderate-to-severe Sjögren’s ...

Importantly, in all of the divergent cases, Northstar Response results were concordant with the ground truth substantiated by imaging and/or biopsy, indicating that the tumor-informed results were ...